Senescence-associated reprogramming promotes cancer stemness
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a stress-responsive cell-cycle arrest program that terminates the further expansion of (pre-)malignant cells. Key signalling components of the senescence machinery, such as p16 INK4a, p21 CIP1 and p53, as well as trimethylation of lysine 9 at histone H3 (H3K9me3), also operate as critical regulators of stem-cell functions (which are collectively termed 'stemness'). In cancer cells, a gain of stemness may have profound implications for tumour aggressiveness and clinical outcome. Here we investigated whether chemotherapy-induced senescence could change stem-cell-related properties of malignant cells. Gene expression and functional analyses comparing senescent and non-senescent B-cell lymphomas from Eμ-Myc transgenic mice revealed substantial upregulation of an adult tissue stem-cell signature, activated Wnt signalling, and distinct stem-cell markers in senescence. Using genetically switchable models of senescence targeting H3K9me3 or p53 to mimic spontaneous escape from the arrested condition, we found that cells released from senescence re-entered the cell cycle with strongly enhanced and Wnt-dependent clonogenic growth potential compared to virtually identical populations that had been equally exposed to chemotherapy but had never been senescent. In vivo, these previously senescent cells presented with a much higher tumour initiation potential. Notably, the temporary enforcement of senescence in p53-regulatable models of acute lymphoblastic leukaemia and acute myeloid leukaemia was found to reprogram non-stem bulk leukaemia cells into self-renewing, leukaemia-initiating stem cells. Our data, which are further supported by consistent results in human cancer cell lines and primary samples of human haematological malignancies, reveal that senescence-associated stemness is an unexpected, cell-autonomous feature that exerts its detrimental, highly aggressive growth potential upon escape from cell-cycle blockade, and is enriched in relapse tumours. These findings have profound implications for cancer therapy, and provide new mechanistic insights into the plasticity of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent senescent cells are known to exert detrimental long-term effects on organ function and can promote tumorigenesis33,96,112,177,178.”
From COVID-19 and cellular senescence (2023) · cites this paper as [177]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the senescence programme is associated with enhanced stemness through cell- autonomous and cell- non- autonomous mechanisms”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Continuous transcriptional or, more generally, functional changes in senescent cells, and the permanent need to actively maintain senescencesupporting transcription puts the stability of cell cycle arrest at risk, occasionally leading to the restoration of proliferative properties with a potentially detrimental effect on tumour suppression 5,79 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conversely, inactivation of Tp53 , the genes encoding either one of the three Rb family members or Suv39h1 in already senescent cells enables cell cycle re- entry out of the terminal arrest condition 5,125,126 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, retained senescence- associated gain of stemness in senescence escapers has been demonstrated in samples derived from patients with relapsed diffuse large B cell lymphoma that exhibited strong enrichment for WNT signalling activity reminiscent of senescence- associated stemness 5 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measured
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Rappsilber, J., Mann, M., & Ishihama, Y. (2007) · Nature Protocols · doi:10.1038/nprot.2007.261 · Cited by 4,641
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Cited by
Items 201–300 of 1,000
“Mitotic Slippage” and Extranuclear DNA in Cancer Chemoresistance: A Focus on Telomeres
Salmiņa, K., Bojko, A., Inashkina, I., Staniak, K., Dudkowska, M., Podlesniy, P., Rūmnieks, F., Vainshelbaum, N. M., Pjanova, D., Sikora, E., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082779 · Cited by 67
Solé, L., Lobo-Jarne, T., Álvarez-Villanueva, D., Alonso-Marañón, J., Guillén, Y., Guix, M., Sangrador, I., Rozalén, C., Vert, A., Barbachano, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30382-9 · Cited by 60
Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword
Battram, A. M., Bachiller, M., & Martín-Antonio, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124346 · Cited by 69
Tumor Dormancy: Implications for Invasion and Metastasis
Gomatou, G., Syrigos, N. K., Vathiotis, I. A., & Kotteas, E. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094862 · Cited by 66
Genome Instability and DNA Repair in Somatic and Reproductive Aging
Panier, S., Wang, S., & Schumacher, B. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051122-093128 · Cited by 71
Therapy-induced polyploidization and senescence: Coincidence or interconnection?
Sikora, E., Czarnecka‐Herok, J., Bojko, A., & Sunderland, P. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.015 · Cited by 68
Targeting mTOR for Anti-Aging and Anti-Cancer Therapy
Fu, W., & Wu, G. (2023) · Molecules · doi:10.3390/molecules28073157 · Cited by 66
Fiorillo, M., Sotgia, F., & Lisanti, M. P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00677 · Cited by 64
Aging and stress induced β cell senescence and its implication in diabetes development
Li, N., Liu, F., Yang, P., Xiong, F., Yu, Q., Li, J., Zhou, Z., Zhang, S., & Wang, C.-Y. (2019) · Aging · doi:10.18632/aging.102432 · Cited by 56
An, S., Cho, S.-Y., Kang, J., Lee, S., Kim, H.-S., Min, D.-J., Son, E., & Cho, K.-H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920338117 · Cited by 60
Self-citationThe Jekyll and Hyde of Cellular Senescence in Cancer
Demirci, D., Dayanc, B., Mazi, F. A., & Şentürk, Ş. (2021) · Cells · doi:10.3390/cells10020208 · Cited by 69
Shimazaki, R., Takano, S., Satoh, M., Takada, M., Miyahara, Y., Sasaki, K., Yoshitomi, H., Kagawa, S., Furukawa, K., Takayashiki, T., et al. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00614-z · Cited by 67
Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma
Zanoni, M., Sarti, A. C., Zamagni, A., Cortesi, M., Pignatta, S., Arienti, C., Tebaldi, M., Sarnelli, A., Romeo, A., Bartolini, D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04526-0 · Cited by 63
Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation
Chang, M., Dong, Y., Xu, H., Cruickshank‐Taylor, A. B., Kozora, J. S., Behpour, B., & Wang, W. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202315425 · Cited by 63
VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance
Pichol-Thievend, C., Anezo, O., Pettiwala, A. M., Bourmeau, G., Montagne, R., Lyne, A.-M., Guichet, P., Deshors, P., Ballestín, A., Blanchard, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47985-z · Cited by 64
Xiong, J., Dong, L., Lv, Q., Yin, Y., Zhao, J., Ke, Y., Wang, S., Zhang, W., & Wu, M. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1772 · Cited by 66
Luo, J., Sun, T., Liu, Z., Liu, Y., Liu, J., Wang, S., Shi, X., & Zhou, H. (2025) · International Journal of Oral Science · doi:10.1038/s41368-025-00380-w · Cited by 71
Oxidative stress and cellular senescence: Roles in tumor progression and therapeutic opportunities
Jin, P., Feng, X., Huang, C., Li, J., Wang, H. Z., Wang, X., Li, L., & Ma, L. (2024) · MedComm – Oncology · doi:10.1002/mog2.70007 · Cited by 88
Targeting normal and cancer senescent cells as a strategy of senotherapy
Sikora, E., Bielak-Zmijewska, A., & Mosieniak, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100941 · Cited by 56
Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation
Khan, T., Sullivan, M. A., Gunter, J. H., Kryza, T., Lyons, N., He, Y., & Hooper, J. D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.592455 · Cited by 63
Carpenter, V. J., Saleh, T., Lee, S. M., Murray, G. F., Reed, J. C., Souers, A. J., Faber, A. C., Harada, H., & Gewirtz, D. A. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114765 · Cited by 63
Self-citationEscape from senescence: molecular basis and therapeutic ramifications
Evangelou, K., Belogiannis, K., Papaspyropoulos, A., Petty, R., & Gorgoulis, V. G. (2023) · The Journal of Pathology · doi:10.1002/path.6164 · Cited by 62
Dynamic 3D genome reorganization during senescence: defining cell states through chromatin
Shaban, H. A., & Gasser, S. M. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01197-y · Cited by 61
Targeting STING in cancer: Challenges and emerging opportunities
Zhao, K., Huang, J., Zhao, Y., Wang, S., Xu, J., & Yin, K. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188983 · Cited by 63
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas
Reimann, M., Schrezenmeier, J., Richter-Pechanska, P., Dolnik, A., Hick, T. P., Schleich, K., Cai, X., Fan, D. N. Y., Lohneis, P., Maßwig, S., et al. (2021) · Blood · doi:10.1182/blood.2020005244 · Cited by 59
Self-citationRing, N. A. R., Valdivieso, K., Grillari, J., Redl, H., & Ogrodnik, M. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.04.005 · Cited by 60
Wang, J., Shao, F., Yu, Q., Ye, L., Wusiman, D., Wu, R., Tuo, Z., Wang, Z., Li, D., Cho, W. C. S., et al. (2025) · Research · doi:10.34133/research.0612 · Cited by 72
Wu, P., Liu, Q., Wang, Q., Qian, H., Yu, L., Liu, B., & Li, R. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s166104 · Cited by 59
Wang, J., Zheng, X., Qin, Z., Wei, L., Lu, Y., Qiu, P., Gao, Y., Zhang, X., Zhang, X., Li, Z., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006853 · Cited by 61
Lamichane, S., Baek, S. H., Kim, Y.-J., Park, J., Lamichane, B. D., Jang, W. B., Ji, S., Lee, N. K., Li, D., Kim, D. Y., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6492029 · Cited by 61
Chakrabarty, A., Chakraborty, S., Bhattacharya, R., & Chowdhury, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.674354 · Cited by 62
Tetraploidy in cancer and its possible link to aging
Tanaka, K., Goto, H., Nishimura, Y., Kasahara, K., Mizoguchi, A., & Inagaki, M. (2018) · Cancer Science · doi:10.1111/cas.13717 · Cited by 61
Menon, D. R., Hammerlindl, H., Torrano, J., Schaider, H., & Fujita, M. (2020) · Theranostics · doi:10.7150/thno.42523 · Cited by 58
Azazmeh, N., Assouline, B., Winter, E., Ruppo, S., Nevo, Y., Maly, A., Meir, K., Witkiewicz, A. K., Cohen, J., Rizou, S. V., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16475-3 · Cited by 57
Cellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 58
Bojko, A., Staniak, K., Czarnecka‐Herok, J., Sunderland, P., Dudkowska, M., Śliwińska, M. A., Salmiņa, K., & Sikora, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176084 · Cited by 59
Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer
Banerjee, P., Kotla, S., Velatooru, L. R., Abe, R. J., Olmsted‐Davis, E. A., Cooke, J. P., Schadler, K., Deswal, A. M., Herrmann, J., Lin, S. H., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.763930 · Cited by 57
Desaulniers, D. M., Vasseur, P., Jacobs, A. C., Aguila, M. C., Ertych, N., & Jacobs, M. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010969 · Cited by 60
Khouzam, R. A., Janji, B., Thiery, J., Zaarour, R. F., Chamseddine, A. N., Mayr, H., Savagner, P., Kiéda, C., Gad, S., Buart, S., et al. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.008 · Cited by 58
Wang, P., Liao, B., Gong, S., Guo, H., Zhao, L., Liu, J., & Wu, N. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07617-w · Cited by 58
The Premature Senescence in Breast Cancer Treatment Strategy
Milczarek, M. (2020) · Cancers · doi:10.3390/cancers12071815 · Cited by 62
Cytoplasmic chromatin fragments-from mechanisms to therapeutic potential.
Miller, K. N., Dasgupta, N., Liu, T., Adams, P. D., & Vizioli, M. G. (2021) · eLife · doi:10.7554/elife.63728 · Cited by 55
Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancer
Saleh, T., Bloukh, S., Hasan, M., & Shboul, S. A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188994 · Cited by 56
Therapy-induced senescence is a transient drug resistance mechanism in breast cancer
Bajtai, E., Kiss, C., Bakos, É., Langó, T., Lovrics, A., Schád, É., Tisza, V., Hegedűs, K., Fürjes, P., Szabó, Z., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02310-0 · Cited by 65
The senescence-associated secretory phenotype: Fueling a wound that never heals
Pulido, T., Velarde, M. C., & Alimirah, F. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111561 · Cited by 57
Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells
Lafontaine, J., Cardin, G. B., Malaquin, N., Boisvert, J.-S., Rodier, F., & Wong, P. (2021) · Cancers · doi:10.3390/cancers13030386 · Cited by 54
Zhou, X., Luo, J., Xie, H., Wei, Z., Li, T., Liu, J., Liao, X., Zhu, G., & Peng, T. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01201-3 · Cited by 54
Reactive oxygen species in cancer stem cells of head and neck squamous cancer
Qian, X., Nie, X., Yao, W., Klinghammer, K., Sudhoff, H., Kaufmann, A. M., & Albers, A. E. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.06.001 · Cited by 53
Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
Sridharan, S., Howard, C. M., Tilley, A. M. C., Subramaniyan, B., Tiwari, A. K., Ruch, R. J., & Raman, D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01003 · Cited by 54
Dark Side of Cytotoxic Therapy: Chemoradiation-Induced Cell Death and Tumor Repopulation
Jiang, M., Gu, D.-N., Dai, J., Huang, Q., & Tian, L. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.01.018 · Cited by 57
Ribosomal DNA and the nucleolus at the heart of aging
Kasselimi, E., Pefani, D., Taraviras, S. L., & Lygerou, Z. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.12.007 · Cited by 54
Senescent cells in cancer therapy: why and how to remove them
Zhang, J., Zhang, D., & Yu, B. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.002 · Cited by 59
Inflammation and cancer: friend or foe?
Smith, A. D. T., Córdoba-Hernandez, S., Mejía-Guarnizo, L. V., Monroy-Camacho, P. S., & Rodríguez-García, J. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1385479 · Cited by 58
Guo, Z., Zhang, Y., Gong, Y., Li, G., Pan, J., Dou, D., Ma, K., Cui, C., Liu, Y., & Zhu, X. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.029 · Cited by 53
Senescence Elicits Stemness: A Surprising Mechanism for Cancer Relapse
Dou, Z., & Berger, S. L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.009 · Cited by 56
Cellular Reprogramming as a Therapeutic Target in Cancer
Xiong, S., Ye, F., & Cheng, L. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.05.001 · Cited by 54
Zottel, A., Šamec, N., Kump, A., Dall’Olio, L. R., Dominkuš, P. P., Romih, R., Hudoklin, S., Mlakar, J., Nikitin, D. M., Sorokin, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228491 · Cited by 54
Cellular senescence in the tumor microenvironment and context‐specific cancer treatment strategies
Yasuda, T., Baba, H., & Ishimoto, T. (2021) · FEBS Journal · doi:10.1111/febs.16231 · Cited by 60
Cellular senescence promotes progenitor cell expansion during axolotl limb regeneration
Yu, Q., Walters, H. E., Pasquini, G., Pal Singh, S., Lachnit, M., Oliveira, C. R., León-Periñán, D., Petzold, A., Kesavan, P., Subiran Adrados, C., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.09.009 · Cited by 52
Liang, X., Zhang, Y., Zhou, J., Bu, Z., Liu, J., & Zhang, K. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214824 · Cited by 54
Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic manner
Warde, K. M., Smith, L., Liu, L., Stubben, C., Lohman, B. K., Willett, P. W., Ammer, J. L., Castaneda-Hernandez, G., Imodoye, S. O., Zhang, C., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00420-2 · Cited by 52
Ji, J., Ding, K., Cheng, B., Zhang, X., Luo, T., Huang, B., Hao, Y., Chen, Y., Xu, X., Lin, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202304609 · Cited by 58
Cellular senescence in cancer: molecular mechanisms and therapeutic targets
Jin, P., Duan, X., Li, L., Zhou, P., Zou, C., & Xie, K. (2024) · MedComm · doi:10.1002/mco2.542 · Cited by 57
Zang, J., Zheng, M., Cao, X., Zhang, Y., Zhang, Y.-F., Gao, X.-Y., Cao, Y., Shi, M., Han, H., & Liang, L. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00598-7 · Cited by 51
MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities
Bisso, A., Sabò, A., & Amati, B. B. (2019) · Immunological Reviews · doi:10.1111/imr.12734 · Cited by 57
Ghorai, A., Mahaddalkar, T., Thorat, R. A., & Dutt, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.023 · Cited by 52
Liu, P., Tang, Q., Chen, M., Chen, W., Lu, Y., Liu, Z., & He, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.589908 · Cited by 54
Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell Regulation
Nathansen, J., Meyer, F., Müller, L., Schmitz, M., Borgmann, K., & Dubrovska, A. (2021) · Cancers · doi:10.3390/cancers13194818 · Cited by 54
Lv, X., Liu, C., Liu, S., Li, Y., Wang, W., Li, K., Hua, F., Cui, B., Zhang, X., Yu, J., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.015 · Cited by 50
Targeting CDK4/6 for Anticancer Therapy
Qi, J., & Ouyang, Z. (2022) · Biomedicines · doi:10.3390/biomedicines10030685 · Cited by 53
Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response
Stefanski, C. D., & Prosperi, J. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217844 · Cited by 59
Identification of GL-V9 as a novel senolytic agent against senescent breast cancer cells
Yang, D., Tian, X., Ye, Y., Liang, Y., Zhao, J., Wu, T., & Lu, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119196 · Cited by 49
Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention
Tamamouna, V., Pavlou, E., Neophytou, C. M., Papageorgis, P., & Costeas, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213931 · Cited by 52
Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing
Mongiardi, M. P., Pellegrini, M., Pallini, R., Levi, A., & Falchetti, M. L. (2021) · Cancers · doi:10.3390/cancers13030484 · Cited by 53
González-Meljem, J. M., & Martínez-Barberá, J. P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03798-7 · Cited by 53
Escape from oncogene-induced senescence is controlled by POU2F2 and memorized by chromatin scars
Martínez‐Zamudio, R. I., Stefa, A., de Freitas, J. A. N. L. F., Vasilopoulos, T., Simpson, M., Doré, G. R. G., Roux, P., Galan, M. A., Chokshi, R. J., Bischof, O., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100293 · Cited by 52
Cellular senescence and hematological malignancies: From pathogenesis to therapeutics
Hu, D., Yuan, S., Zhong, J., Liu, Z., Wang, Y., Liu, L., Li, J., Wen, F., Liu, J., & Zhang, J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107817 · Cited by 49
Cellular senescence in neuroinflammatory disease: new therapies for old cells?
Nelke, C., Schroeter, C. B., Pawlitzki, M., Meuth, S. G., & Ruck, T. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.07.003 · Cited by 50
An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and Atherosclerosis
Abe, J., Imanishi, M., Li, S., Zhang, A., Ko, K. A., Samanthapudi, V. S. K., Lee, L.-L., Paniagua-Bojorges, A., Gi, Y. J., Hobbs, B. P., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.322017 · Cited by 48
A tale of the good and bad: Cell senescence in bone homeostasis and disease
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.03.005 · Cited by 45
Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms
Aldonza, M. B. D., Ku, J., Hong, J., Kim, D., Yu, S. J., Lee, M.-S., Prayogo, M. C., Tan, S., Kim, D., Han, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aav7416 · Cited by 48
Self-citationRole of autophagy in tumor response to radiation: Implications for improving radiotherapy
Roy, A., Bera, S., Saso, L., & Dwarakanath, B. S. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.957373 · Cited by 49
Therapy-induced senescent tumor cells in cancer relapse
Song, K., Wang, J., & Huang, D. (2023) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2023.09.001 · Cited by 57
Senescent cells at the crossroads of aging, disease, and tissue homeostasis
Kuehnemann, C., & Wiley, C. D. (2023) · Aging Cell · doi:10.1111/acel.13988 · Cited by 50
Lin, G., Gao, Z., Wu, S., Zheng, J., Guo, X., Zheng, X., & Chen, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-54135-4 · Cited by 49
Chen, Z., Zhou, J., Wu, Y., Chen, F., Li, J., Tao, L., Tian, Y., Wang, H., Li, Z., Li, Z., et al. (2024) · Oncogene · doi:10.1038/s41388-024-02956-y · Cited by 46
Yu, Y., Schleich, K., Yue, B., Ji, S., Lohneis, P., Kemper, K., Silvis, M. R., Qutob, N., van Rooijen, E., Werner-Klein, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.009 · Cited by 46
Self-citationCircumventing senescence is associated with stem cell properties and metformin sensitivity
Deschênes‐Simard, X., Parisotto, M., Rowell, M., Le Calvé, B., Igelmann, S., Moineau‐Vallée, K., Saint‐Germain, E., Kalegari, P., Bourdeau, V., Kottakis, F., et al. (2019) · Aging Cell · doi:10.1111/acel.12889 · Cited by 45
Adedokun, K. A., Imodoye, S. O., Bello, I. O., Lanihun, A.-A. A., & Bello, I. O. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90593-0.00017-4 · Cited by 64
The foreign body response: emerging cell types and considerations for targeted therapeutics
Yang, B., Rutkowski, N., & Elisseeff, J. H. (2023) · Biomaterials Science · doi:10.1039/d3bm00629h · Cited by 46
Cellular senescence in liver diseases: From molecular drivers to therapeutic targeting
Du, K., Umbaugh, D. S., Ren, N., & Diehl, A. M. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.08.021 · Cited by 47
Harnessing α- l -fucosidase for in vivo cellular senescence imaging
Koo, S., Won, M., Li, H., Kim, W. Y., Li, M., Yan, C., Sharma, A. K., Guo, Z., Zhu, W., Sessler, J. L., et al. (2021) · Chemical Science · doi:10.1039/d1sc02259h · Cited by 47
Senescence and Immunoregulation in the Tumor Microenvironment
Ruhland, M. K., & Alspach, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.754069 · Cited by 52
The Achilles’ heel of cancer survivors: fundamentals of accelerated cellular senescence
Shafqat, S., Arana‐Chicas, E., Shafqat, A., & Hashmi, S. K. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158452 · Cited by 46
Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs
Chang, M., Gao, F., Gnawali, G. R., Xu, H., Dong, Y., Meng, X., Li, W., Wang, Z., Lopez, B., Carew, J. S., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00152 · Cited by 44
Grossmann, L. D., Chen, C.-H., Uzun, Y., Thadi, A., Wolpaw, A. J., Louault, K., Goldstein, Y., Surrey, L. F., Martínez, D., Calafatti, M., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0046 · Cited by 45
Wang, Q., Yen, Y., Xie, C., Liu, F., Liu, Q., Wei, J., Yu, L., Wang, L., Meng, F., Li, R., et al. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1886378 · Cited by 44
Senescence-mediated anticancer effects of quercetin
Özsoy, S., Becer, E., & Vatansever, H. S. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.04.007 · Cited by 45
Spatial resolution of cellular senescence dynamics in human colorectal liver metastasis
Garbarino, O., Lambroia, L., Basso, G., Marrella, V., Franceschini, B., Soldani, C., Pasqualini, F., Giuliano, D., Costa, G., Peano, C., et al. (2023) · Aging Cell · doi:10.1111/acel.13853 · Cited by 43
The Emerging Role of Accelerated Cellular Senescence in Periodontitis
Aquino-Martínez, R. (2023) · Journal of Dental Research · doi:10.1177/00220345231154567 · Cited by 45
Metadata
- Authors
- Milanovic, M., Fan, D. N. Y., Belenki, D., Däbritz, J. H. M., Zhao, Z., Yu, Y., Dörr, J. R., Dimitrova, L., Lenze, D., Monteiro Barbosa, I. A., Mendoza-Parra, M. A., Kanashova, T., Metzner, M., Pardon, K., Reimann, M., Trumpp, A., Dörken, B., Zuber, J., Gronemeyer, H., Hummel, M., Dittmar, G., Lee, S., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- German Cancer Research Center (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Max Delbrück Center (DE)
- Centre National de la Recherche Scientifique (FR)
- Research Institute of Molecular Pathology (AT)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2017-12-20
- Volume
- 553
- Issue
- 7686
- Pages
- 96-100
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777786283
- Cited by
- 1,131
- References
- 60
- Citations by year
- 2026: 110 · 2025: 137 · 2024: 154 · 2023: 181 · 2022: 149 · 2021: 140 · 2020: 125 · 2019: 84 · 2018: 49 · 2017: 1
- FWCI
- 52.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, cancer stem cells, chemotherapy-induced senescence, senescence escape, Wnt signaling, H3K9me3, p53, p16INK4a, p21, B-cell lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, hematologic malignancies, clonogenic growth, self-renewal
- MeSH terms
- Animals, Clone Cells, Female, Humans, Male, Mice, Transgenic, Phenotype, Neoplastic Stem Cells, Biomarkers, Lymphoma, B-Cell, Cellular Senescence, Cell Line, Tumor, Cell Proliferation, Mice, Cell Cycle Checkpoints, Wnt Signaling Pathway, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.